Cytokinetics ticker

Author: dpfu

August undefined, 2024

WebDec 30, 2024 · Cytokinetics, Incorporated is a late-stage biopharmaceutical company. It is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases. It is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. WebCytokinetics, Incorporated (CYTK) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. 2W 10W 9M. 34.71 -0.54 (-1.53%) As of 10:34AM EDT. Market open.

Cytokinetics Stock Quote. CYTK - Stock Price, News, Charts, …

WebApr 7, 2024 · Cytokinetics, Inc.’s trailing 12-month revenue is $94.6 million with a -411.2% profit margin. Year-over-year quarterly sales growth most recently was -96.4%. Analysts expect adjusted earnings to reach $-4.363 per share for the current fiscal year. Cytokinetics, Inc. does not currently pay a dividend. The Biotechnology and Medical … Web2 days ago · Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as … how and when to prune wisteria uk

Cytokinetics Incorporated Stock price history chart earnings ticker

WebCytokinetics, Inc. (CYTK) Stock Price & News - Google Finance Markets +0.85 Home CYTK • NASDAQ Cytokinetics, Inc. Follow Share $35.84 Apr 3, 9:39:48 AM GMT-4 · … WebJul 19, 2024 · The data suggest that Cytokinetics (ticker: CYTK) drug could become a potent rival to a similar investigational drug that Bristol Myers Squibb (BMY) acquired last … WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has … how and when to prune standard roses

Cytokinetics Announces Topline Results From METEORIC-HF

Bonnie Charpentier - Cytokinetics Insider Transactions

WebApr 13, 2024 · Issuer Name and Ticker or Trading Symbol CYTOKINETICS INC [ CYTK] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director: 10% Owner: X: Officer (give title below) Other (specify below) EVP Research & Development: 3. Date of Earliest Transaction (Month/Day/Year) how many hours is 3gb of hotspotWebwww.cytonics.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology … how and when to seed a lawn

"WebMar 1, 2024 · Cytokinetics Inc (CYTK) SEC Filing 8-K Material Event for the period ending Wednesday, March 1, 2024. Home. SEC Filings. Cytokinetics Inc (CYTK) 8-K Material Event Wed Mar 01 2024; SEC Filings. CYTK Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. Manager Portfolios. " - Cytokinetics ticker

Cytokinetics ticker

WebFeb 17, 2024 · It is currently -18.08% from its 52-week high and 51.01% from its 52-week low. How much is Cytokinetics stock worth today? ( NASDAQ: CYTK) Cytokinetics currently has 94,631,001 outstanding shares. With Cytokinetics stock trading at $45.71 per share, the total value of Cytokinetics stock (market capitalization) is $4.33B. WebCytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential …

Did you know?

WebCytokinetics Incorporated 280 East Grand Avenue South San Francisco, CA 94080 United States. Website. Investor relation . Ratios; Stock Price Chart; Annual Returns; Financial … WebCytokinetics, Incorporated CYTK: Raising target price to $38.00 CYTOKINETICS INC has an Investment Rating of HOLD; a target price of $38.000000; an Industry Subrating of … Find the latest Cytokinetics, Incorporated (CYTK) stock discussion in Yahoo … See the company profile for Cytokinetics, Incorporated (CYTK) including business … View the basic CYTK option chain and compare options of Cytokinetics, … SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- … Discover historical prices for CYTK stock on Yahoo Finance. View daily, weekly or … At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio … Find out all the key statistics for Cytokinetics, Incorporated (CYTK), … Get the detailed quarterly/annual income statement for Cytokinetics, Incorporated … Find out the direct holders, institutional holders and mutual fund holders for … See Cytokinetics, Incorporated (CYTK) Environment, Social and Governance …

WebApr 29, 2004 · Cytokinetics has raised a total of $1.1B in funding over 8 rounds. Their latest funding was raised on Jul 1, 2024 from a Post-IPO Debt round. Cytokinetics is … WebJun 27, 2024 · Cytokinetics ( NASDAQ: CYTK) is a developer of small molecule drugs for cardiovascular and neuromuscular diseases of impaired muscle function. The lead drug …

Web2 days ago · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential … WebMar 4, 2024 · Today is shaping up negative for Cytokinetics, ... (ticker: BBBY) stock was down nearly 20% at 83 cents. In a reverse stock split, each outstanding share is converted into a fraction of the share.

WebApr 6, 2024 · Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as …

WebNov 1, 2024 · SOUTH SAN FRANCISCO, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on October 29, 2024 it granted stock options to purchase an aggregate... how and when to refinance your carWebJun 27, 2024 · CYTK has a market cap of $4.05bn and a cash balance of $686mn. Research and development expenses for the first quarter 2024 were $45.9 million, while general and administrative expenses were $33.1... how and when to prune tomato plantsWebCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, … how and when to reclaim s455 taxWebCytokinetics is a Biotechnology Research, Drug Manufacturing & Research, and Biopharma company located in South San Francisco, California with $26.00 Million in revenue and 495 employees. Find top employees, contact details and business statistics at RocketReach. ... Ticker: CYTK Revenue: $26 million: Funding: $222.70 Million: … how and when to prune salviaWebMar 6, 2024 · SOUTH SAN FRANCISCO, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the company is scheduled to participate in the following investor ... how many hours is 3 units in collegeWebMar 31, 2024 · Cytokinetics Muscle Biology Therapies Home empowering muscle empowering lives Cytokinetics is committed to our mission of developing potential medicines that may improve the … how and when to refinance your homeWebCytokinetics is a biopharmaceutical company with a focus on the discovery, development, and commercialization of muscle activators and muscle inhibitors as potential treatments … how and when to take acv